These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3460626)

  • 21. High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia.
    Hines JD; Oken MM; Mazza JJ; Keller AM; Streeter RR; Glick JH
    J Clin Oncol; 1984 Jun; 2(6):545-9. PubMed ID: 6233399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anthracyclines in the treatment of acute nonlymphocytic leukemias.
    Boiron M; Jacquillat C; Marty M; Weil M; Gisselbrecht C
    Cancer Treat Rep; 1981; 65 Suppl 4():73-6. PubMed ID: 6955013
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of amsacrine plus intermediate-dose cytosine arabinoside in relapsed and refractory acute nonlymphocytic leukemia.
    Dekker AW; Punt K; Verdonck LF
    Haematol Blood Transfus; 1987; 30():333-5. PubMed ID: 3623240
    [No Abstract]   [Full Text] [Related]  

  • 25. Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients.
    Tilly H; Castaigne S; Bordessoule D; Sigaux F; Daniel MT; Monconduit M; Degos L
    Cancer; 1985 Apr; 55(8):1633-6. PubMed ID: 3978558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consolidation therapy without maintenance for acute non-lymphoblastic leukaemia.
    Roberts MM; Juttner CA; Blunden RW; Horvath N; To LB; Ho JQ; Dart GW; Kimber RJ
    Med J Aust; 1988 Feb; 148(4):181-3. PubMed ID: 3340044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose cytosine arabinoside in the consolidation therapy of acute nonlymphocytic leukemia in remission.
    Takaku F; Urabe A; Mizoguchi H; Hoshino S; Toyama K; Tanaka K; Nomura T; Dan K; Fujioka S; Saito T
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):55-7. PubMed ID: 3589698
    [No Abstract]   [Full Text] [Related]  

  • 28. Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes.
    Krug U; Röllig C; Koschmieder A; Heinecke A; Sauerland MC; Schaich M; Thiede C; Kramer M; Braess J; Spiekermann K; Haferlach T; Haferlach C; Koschmieder S; Rohde C; Serve H; Wörmann B; Hiddemann W; Ehninger G; Berdel WE; Büchner T; Müller-Tidow C; ;
    Lancet; 2010 Dec; 376(9757):2000-8. PubMed ID: 21131036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gastrointestinal symptoms of aclacinomycin A in patients with adult acute nonlymphocytic leukemia--comparison of BH-AC-DMP therapy and BH-AC-AMP therapy].
    Kawano F; Tajima H; Matsuoka Y; Asou N; Takatsuki K
    Rinsho Ketsueki; 1985 Apr; 26(4):494-8. PubMed ID: 3862889
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of the day 6 bone marrow to alter remission induction therapy in patients with acute myeloid leukaemia: a leukemia intergroup study.
    Browman G; Preisler H; Raza A; Syracuse K; Azarnia N; Benger A; Chervenick P; D'Arrigo P; Doeblin T; Goldberg J
    Br J Haematol; 1989 Apr; 71(4):493-7. PubMed ID: 2653407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Full remission of acute non-lymphatic leukemia lasting for 16 months following combination therapy with aclacinomycin A].
    Beck JD
    Monatsschr Kinderheilkd; 1986 Aug; 134(8):547-9. PubMed ID: 3464845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of follow-up studies on prognosis after immunotherapy with bestatin in acute nonlymphocytic leukemia].
    Ota K; Kurita S; Yamada K; Masaoka T; Uzuka Y; Ogawa N
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1017-25. PubMed ID: 3963846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of the CFU-C assay in acute nonlymphocytic leukemia.
    Kirshner JJ; Goldberg J; Nelson DA; Gottlieb AJ
    Am J Med; 1982 Apr; 72(4):615-19. PubMed ID: 7041644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies with anthracyclines in pediatric acute nonlymphocytic leukemia.
    Chard RL
    Cancer Treat Rep; 1981; 65 Suppl 4():77-81. PubMed ID: 6179617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring the remission induction therapy of acute nonlymphoblastic leukemia by bone marrow cell culture criteria.
    Bohinjec J; Zontar D; Kralj J
    Leuk Res; 1985; 9(3):369-73. PubMed ID: 3999798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensive maintenance therapy improves survival in adult acute nonlymphocytic leukemia: an eight-year follow-up.
    Dutcher JP; Wiernik PH; Markus S; Weinberg V; Schiffer CA; Harwood KV
    Leukemia; 1988 Jul; 2(7):413-9. PubMed ID: 3393023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A four-year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemia.
    Keating MJ; Smith TL; McCredie KB; Bodey GP; Hersh EM; Gutterman JU; Gehan E; Freireich EJ
    Cancer; 1981 Jun; 47(12):2779-88. PubMed ID: 6942906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
    Wolff SN; Herzig RH; Phillips GL; Lazarus HM; Greer JP; Stein RS; Ray WA; Herzig GP
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):12-7. PubMed ID: 3589687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose VP-16 with intermediate-dose cytosine arabinoside in the treatment of relapsed acute nonlymphocytic leukemia.
    Chan HY; Meyers FJ; Lewis JP
    Cancer Chemother Pharmacol; 1987; 20(3):265-6. PubMed ID: 3677301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drugs.
    Park CH; Wiernik PH; Morrison FS; Amare M; Van Sloten KV; Maloney TR
    Cancer Res; 1983 May; 43(5):2346-9. PubMed ID: 6572563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.